downloadDownload

Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity

assignment_turned_inproject01 Apr 2012(Started)-29 Feb 2016(Ended)Closed

Funder: National Institutes of HealthProject code: 5R01HL107291-03

Funded under: NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Funder Contribution: 373,625 USD

Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity

- Summary
- DMPs

Partners

UNIVERSITY OF VERMONT & ST AGRIC COLLEGE

Data Management Plans

Start a new DMP in Argos

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=nih_________::f11f1ad60a4be7e23cf968120f3e2af3&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity

Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity

Loading